{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:29Z","timestamp":1753892849830,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>We present a male patient carrying a pathogenic MECP2 p. Arg179Trp variant with predominant negative psychiatric features and multilevel evidence of mitochondrial dysfunction who responded to the cariprazine treatment. He had delayed speech development and later experienced severe social anxiety, learning disabilities, cognitive slowing, and predominant negative psychiatric symptoms associated with rigidity. Clinical examinations showed multisystemic involvement. Together with elevated ergometric lactate levels, the clinical picture suggested mitochondrial disease, which was also supported by muscle histopathology. Exploratory transcriptome analysis also revealed the involvement of metabolic and oxidative phosphorylation pathways. Whole-exome sequencing identified a pathogenic MECP2 variant, which can explain both the dopamine imbalance and mitochondrial dysfunction in this patient. Mitochondrial dysfunction was previously suggested in classical Rett syndrome, and we detected related phenotype evidence on multiple consistent levels for the first time in a MECP2 variant carrier male. This study further supports the importance of the MECP2 gene in the mitochondrial pathways, which can open the gate for more personalized therapeutic interventions. Good cariprazine response highlights the role of dopamine dysfunction in the complex psychiatric symptoms of Rett syndrome. This can help identify the optimal treatment strategy from a transdiagnostic perspective instead of a classical diagnostic category.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1301272","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:36:38Z","timestamp":1704429398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications"],"prefix":"10.3389","volume":"14","author":[{"given":"Peter","family":"Balicza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andras","family":"Gezsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariann","family":"Fedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit C.","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniko","family":"Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi Agnes","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Judit","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet."},{"volume-title":"MECP2 Disorders","year":"1993","author":"Kaur","key":"B2"},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"170216","DOI":"10.1098\/rsob.170216","article-title":"Rett syndrome: a neurological disorder with metabolic components","volume":"8","author":"Kyle","year":"2018","journal-title":"Open Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/hmg\/10.9.941","article-title":"MECP2 is highly mutated in X-linked mental retardation","volume":"10","author":"Couvert","year":"2001","journal-title":"Hum Mol Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.3390\/ijms22179610","article-title":"MECP2-related disorders in males","volume":"22","author":"Pascual-Alonso","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejpn.2021.05.013","article-title":"MECP2-related conditions in males: a systematic literature review and 8 additional cases","volume":"34","author":"Inuzuka","year":"2021","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc."},{"article-title":"MECP2 Duplication Syndrome","year":"1993","author":"Van","key":"B9"},{"key":"B10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmg.2007.049452","article-title":"MECP2 mutations in males","volume":"44","author":"Villard","year":"2007","journal-title":"J Med Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/jhg.2015.118","article-title":"MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability","volume":"61","author":"Bianciardi","year":"2016","journal-title":"J Hum Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","article-title":"MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions","volume":"27","author":"Kishi","year":"2004","journal-title":"Mol Cell Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","article-title":"MeCP2: The genetic driver of Rett syndrome epigenetics","volume":"12","author":"Good","year":"2021","journal-title":"Front Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","article-title":"Rett syndrome: a complex disorder with simple roots","volume":"16","author":"Lyst","year":"2015","journal-title":"Nat Rev Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/biom11070967","article-title":"Transcriptomic and epigenomic landscape in Rett syndrome","volume":"11","author":"Marano","year":"2021","journal-title":"Biomolecules."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2017.00058","article-title":"Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies","volume":"11","author":"Shulyakova","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41593-018-0270-6","article-title":"Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing","volume":"21","author":"Renthal","year":"2018","journal-title":"Nat Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ajmg.1320250512","article-title":"Clinical recognition of Rett syndrome","volume":"1","author":"Philippart","year":"1986","journal-title":"Am J Med Genet Suppl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/088307389000500311","article-title":"Rett syndrome: a mitochondrial disease?","volume":"5","author":"Eeg-Olofsson","year":"1990","journal-title":"J Child Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2169\/internalmedicine.8629-21","article-title":"Diagnostic values of venous peak lactate, lactate-to-pyruvate ratio, and fold increase in lactate from baseline in aerobic exercise tests in patients with mitochondrial diseases","volume":"61","author":"Kurihara","year":"2022","journal-title":"Intern Med Tokyo Jpn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0022-510X(98)00170-1","article-title":"Lactate stress test in the diagnosis of mitochondrial myopathy","volume":"159","author":"Finsterer","year":"1998","journal-title":"J Neurol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/PL00007537","article-title":"Lactate-stress testing in 54 patients with mitochondriopathy","volume":"250","author":"Finsterer","year":"2000","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/gim.2017.125","article-title":"Revisiting mitochondrial diagnostic criteria in the new era of genomics","volume":"20","author":"Witters","year":"2018","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"B25","first-page":"312","volume-title":"Structural and Molecular Basis of Skeletal Muscle Diseases","author":"Karpati","year":"2002"},{"key":"B26","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinformatics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/mds.22115","article-title":"Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type","volume":"23","author":"Temudo","year":"2008","journal-title":"Mov Disord Off J Mov Disord Soc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1523\/JNEUROSCI.4624-14.2015","article-title":"MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control","volume":"35","author":"Su","year":"2015","journal-title":"J Neurosci Off J Soc Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"700968","DOI":"10.3389\/fncir.2021.700968","article-title":"Dopaminergic dysregulation in syndromic autism spectrum disorders: insights from genetic mouse models","volume":"15","author":"Kosillo","year":"2021","journal-title":"Front Neural Circuits."},{"key":"B31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: from mouse models to human therapies","volume":"30","author":"Vashi","year":"2019","journal-title":"Mamm Genome Off J Int Mamm Genome Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1007\/s12325-021-01797-5","article-title":"Broad-spectrum antipsychotic for the treatment of schizophrenia: pharmacology, efficacy, and safety","volume":"38","author":"Laszlovszky","year":"2021","journal-title":"Adv Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"827744","DOI":"10.3389\/fpsyt.2022.827744","article-title":"Real-life clinical experience with cariprazine: a systematic review of case studies","volume":"13","author":"Csehi","year":"2022","journal-title":"Front Psychiatry."},{"key":"B34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fphar.2020.00477","article-title":"Early-onset schizophrenia with predominantly negative symptoms: a case study of a drug-naive female patient treated with cariprazine","volume":"11","author":"Molnar","year":"2020","journal-title":"Front Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"825532","DOI":"10.3389\/fpsyt.2021.825532","article-title":"Improving mood and cognitive symptoms in huntington's disease with cariprazine treatment","volume":"12","author":"Molnar","year":"2021","journal-title":"Front Psychiatry."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","article-title":"Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial","volume":"389","author":"N\u00e9meth","year":"2017","journal-title":"Lancet Lond Engl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1756286420938972","DOI":"10.1177\/1756286420938972","article-title":"Wernicke-Korsakoff syndrome associated with mtDNA disease","volume":"13","author":"Jimoh","year":"2020","journal-title":"Ther Adv Neurol Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00210-019-01665-8","article-title":"In vitro effects of antipsychotics on mitochondrial respiration","volume":"392","author":"Cik\u00e1nkov\u00e1","year":"2019","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.schres.2019.09.007","article-title":"Psychiatric drugs impact mitochondrial function in brain and other tissues","volume":"217","author":"Chan","year":"2020","journal-title":"Schizophr Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"38590","DOI":"10.1038\/srep38590","article-title":"From function to phenotype: impaired DNA binding and clustering correlates with clinical severity in males with missense mutations in MECP2","volume":"6","author":"Sheikh","year":"2016","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.a.20247","article-title":"MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-genotype correlation","author":"Gomot","year":"2003","journal-title":"Am J Med Genet A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0387-7604(88)80010-X","article-title":"Abnormal mitochondria in the Rett syndrome","volume":"10","author":"Eeg-Olofsson","year":"1988","journal-title":"Brain Dev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0387-7604(93)90045-A","article-title":"Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study","volume":"15","author":"Dotti","year":"1993","journal-title":"Brain Dev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0387-7604(12)80283-X","article-title":"The Rett syndrome and CSF lactic acid patterns","volume":"14","author":"Matsuishi","year":"1992","journal-title":"Brain Dev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0387-7604(94)90129-5","article-title":"Elevated CSF lactate in the Rett syndrome: cause or consequence?","volume":"16","author":"Lappalainen","year":"1994","journal-title":"Brain Dev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neubiorev.2018.12.009","article-title":"Disturbed redox homeostasis and oxidative stress: Potential players in the developmental regression in Rett syndrome","volume":"98","author":"M\u00fcller","year":"2019","journal-title":"Neurosci Biobehav Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1005679","DOI":"10.1371\/journal.pgen.1005679","article-title":"A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies","volume":"12","author":"Kohda","year":"2016","journal-title":"PLoS Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13023-018-0857-8","article-title":"Transcriptome level analysis in Rett syndrome using human samples from different tissues","volume":"13","author":"Shovlin","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"137629","DOI":"10.1155\/2013\/137629","article-title":"Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients","volume":"2013","author":"Pecorelli","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ygeno.2010.09.004","article-title":"Genomic and transcriptomic analyses distinguish classic Rett and Rett-like syndrome and reveals shared altered pathways","volume":"97","author":"Colak","year":"2011","journal-title":"Genomics."},{"key":"B51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jpeds.2021.09.052","article-title":"Mitochondrial DNA copy number in Rett syndrome caused by Methyl-CpG-binding protein-2 variants","volume":"241","author":"Liu","year":"2022","journal-title":"J Pediatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2202-11-53","article-title":"Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain","volume":"26","author":"Gibson","year":"2010","journal-title":"BMC Neurosci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2020.05.014","article-title":"Proteomic profiling reveals mitochondrial alterations in Rett syndrome","volume":"155","author":"Cicaloni","year":"2020","journal-title":"Free Radic Biol Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"ddad154","DOI":"10.1101\/2023.04.03.535431","article-title":"Systemic proteome phenotypes reveal defective metabolic flexibility in Mecp2 mutants","volume":"15","author":"Zlatic","year":"2023","journal-title":"Hum Mol Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40246-023-00532-1","article-title":"Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach","volume":"17","author":"Pascual-Alonso","year":"2023","journal-title":"Hum Genomics."},{"key":"B56","doi-asserted-by":"publisher","first-page":"111942","DOI":"10.1016\/j.celrep.2022.111942","article-title":"Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation","volume":"42","author":"Sun","year":"2023","journal-title":"Cell Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.stem.2013.09.001","article-title":"Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons","volume":"13","author":"Li","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1016\/j.celrep.2020.02.107","article-title":"Shifts in ribosome engagement impact key gene sets in neurodevelopment and ubiquitination in Rett syndrome","volume":"30","author":"Rodrigues","year":"2020","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1301272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:36:42Z","timestamp":1704429402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1301272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":59,"alternative-id":["10.3389\/fpsyt.2023.1301272"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1301272","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1301272"}}